Thompson III Willard C MD Salisbury, NC - 28144

Thompson III Willard C MD is categorized under Internal Medicine Practitioners in Salisbury, NC and active since 1986.

Thompson III Willard C MD was established in 1986, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Willard Thompson III at the company’s single location by writing to 721 Grove St, Salisbury, North Carolina NC 28144 or by phoning (704) 633-2732. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Thompson III Willard C MD
Contact Person: Willard Thompson III
Address: 721 Grove St, Salisbury, North Carolina 28144
Phone Number: (704) 633-2732
Annual Revenue (USD): $500.000 to $999.999
Founded: 1986
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Thompson III Willard C MD was started in 1986 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Willard Thompson III for inquiries that concern Thompson III Willard C MD by calling the company number (704) 633-2732, as your correspondence is most welcome. Additionally, the physical location of the single location of Thompson III Willard C MD can be found at the coordinates 35.67933,-80.47042 as well as the street address 721 Grove St in Salisbury, North Carolina 28144.

For its online presence, you may visit Thompson III Willard C MD’s website at and engage with its social media outlets through on Twitter and on Facebook.